最新报道脂肪酸合酶(FAS)是治疗肥胖症的潜在靶部位，但目前已知的FAS抑制剂还很少。

Fatty acid synthase (FAS) is reported as a potential new therapeutic target for obesity. However, there are limited known FAS inhibitors presently.

youdao

最新报道脂肪酸合酶(FAS)是治疗肥胖症的潜在靶部位，但目前已知的FAS抑制剂还很少。

Fatty acid synthase (FAS) is reported as a potential new therapeutic target for obesity. However, there are limited known FAS inhibitors presently.

youdao